Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Press Releases

Event Announcement

MAP Congress 2020: Molecular Analysis for Precision Oncology

The Molecular Analysis for Precision oncology (MAP) Congress is designed to answer the critical question about how to integrate the wealth of information coming from the analysis of tumour samples into daily practice.

ESMO Press Release

No Benefit for Post-operative Radiotherapy in Non-small-cell Lung Cancer

Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings